Kojin Therapeutics, Inc.

Biotechnology company · Boston, Massachusetts, United States

Kojin Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Kojin Therapeutics at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2019

SEC CIK1866204

What does Kojin Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $30.2 million sold (2021).

Frequently asked questions about Kojin Therapeutics

Where is Kojin Therapeutics headquartered?

Kojin Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

What does Kojin Therapeutics do?

Kojin Therapeutics, Inc. is a biotechnology company.

When was Kojin Therapeutics founded?

The earliest incorporation on record for Kojin Therapeutics, Inc. is in 2019, according to public company registers.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences